Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-11-14 18:03:24
Reporting Period:
Accepted Time:
2017-11-14 18:03:24
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226288 C James Mullen C/o Insulet Corporation
600 Technology Park Drive, Suite 200
Billerica MA 01821
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-13 2,500 $67.45 5,598 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $67.32 to $67.59. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. Includes 3,098 restricted stock units granted on August 9, 2017, which vest one-half of the total units on August 9, 2018, one-quarter of the total units on August 9, 2019, and one-quarter of the total units on August 9, 2020, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.